Adhesion Barrier Market: Opportunities and Challenges

Posted on 2019-10-11 by MarketsandMarkets in Biotech, Healthcare, Pharmaceuticals // 0 Comments

The adhesion barrier market is expected to reach USD 1.06 billion by 2027 from an estimated USD 0.61 billion in 2019, at a CAGR of 7.2% during the forecast period.

How will the untapped emerging markets provide growth opportunities for players in the adhesion barrier market?

The penetration of adhesion barriers is very low in the Asia Pacific, Latin America, and the Middle East & Africa. In the coming years, countries such as South Korea, China, India, Mexico, and Brazil are expected to offer significant growth opportunities for players operating in the adhesion barrier market as these countries have a large patient base for target indications, such as cardiovascular, orthopedic, general/abdominal, and gynecological disorders.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543

Moreover, surgical procedures such as cardiac surgeries, general and abdominal surgeries, urological surgeries, gynecological surgeries, and orthopedic surgeries are also on the rise in countries across the emerging markets. According to WHO, the number of operations performed in APAC and Latin American countries is increasing at a significant rate annually. In 2012, the annual number of operations performed in China and India was 39.5 million and 12.6 million, respectively. These numbers are expected to increase in the coming years. The increasing disease burden and volume of surgical procedures performed in the emerging markets are expected to create growth opportunities for key players in the adhesion barrier market.

Do stringent regulations result in limited technological innovations in the adhesion barrier market?

The development of new adhesion barriers requires significant investments, and new products generally take more than 7–8 years to gain marketing approval. In the US, the FDA has made it mandatory for adhesion barrier manufacturers to obtain Premarket Approval (PMA) for their products before they are introduced in the market. For this, the manufacturer has to demonstrate proper clinical trial data, which has to be submitted along with an application for PMA. The cost and time required for a product to enter the clinical trial stage and then clear the clinical trials are very high, with minimum chances of the product gaining approval. Also, the possibility of obtaining clinically significant data showing efficacy and safety has been low for most adhesion barriers, barring a few. Hence, despite huge investments in R&D, the risk of failure is very high in the case of adhesion barriers. This is a major factor limiting the development of novel adhesion barriers in the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543

Browse Related Reports:

Surgical Sealants and Adhesives Market by Product (Natural & Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, Albumin, Human blood), Indication (Hemostasis, Tissue Sealing), Application (CNS, Cardiovascular, Cosmetic Surgery) – Global Forecast to 2021

Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) – Forecast to 2023

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Matched content

Editor’s pick